| Immunisation | ITNs | Anti-malaria drugs | ANC | Childbirth | ARVs | FP | TB |
---|---|---|---|---|---|---|---|---|
 | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) |
Number that paid by urban-rural residence | ||||||||
Urban | 193 (55.6%) | 0 (0%) | 280 (83.6%) | 27 (56.3%) | 21 (75.0%) | 1 (100%) | 0 | 1 (25%) |
Rural | 154 (44.4%) | 4 (100%) | 55 (16.4%) | 21 (43.7%) | 7 (25.0%) | 0 | 0 | 3 (75%) |
Chi-square (p-value) | 69.9 (.00001) | 20.1 (.001) | .77 (.44) | 29.1 (.00001) | 2.4 (.17) | .17 (.85) | Na | 11.3 (.012) |
Number that paid by gender | ||||||||
Male | 152 (43.8%) | 0 | 120 (35.8%) | NA | NA | 0 | 0 | 2 (50%) |
Female | 195 (56.2%) | 4 (100%) | 215 (64.2%) | NA | NA | 0 | 0 | 2 (50%) |
Chi-square (p-value) | 11.6 (.001) | 2.3 (.30) | .26 (.63) | Â | Â | Na | 1.7 (.38) | .33 (.63) |
Number that paid by SES | ||||||||
Quintile 1 | 81(23.5%) | 1 (25%) | 36 (10.8%) | 13 (27.1%) | 4 (14.3%) | 0 | 0 | 1 (25%) |
Quintile 2 | 67 (19.4%) | 1 (25%) | 57 (17.1%) | 5 (10.4%) | 4 (14.3%) | 0 | 0 | 2 (50%) |
Quintile 3 | 70 (20.3%) | 1 (25%) | 64 (19.2%) | 6 (12.5%) | 5 (17.9%) | 0 | 0 | 0 |
Quintile 4 | 65 (18.8%) | 1 (25%) | 78 (23.4%) | 15 (31.3%) | 8 (28.6%) | 0 | 0 | 0 |
Quintile 5 | 62 (18.0%) | 0 | 98 (29.4%) | 9 (18.8%) | 7 (25.0%) | 1/165 (0.6%) | 0 | 1 (25%) |
Chi-square (p-value) | 31.4 (.00001) | 2.0 (.73) | 6.3 (.18) | 14.8 (.005) | .54 (.97) | 2.7 (.61) | Â | 5.1 (.28) |
Concentration index | −0.02 | −0.17 | 0.03 | −0.13 | −0.03 | - | - | −0.22 |
Total | 347 | 4 | 335 | 48 | 28 | 1 | 0 | 4 |